Summit Therapeutics PLC's (LON:SUMM, NASDAQ:SMMT) Richard Pye tells Proactive Investors 2017 was a 'landmark' year for them...
Stock Tubes
Showing 20 of 8050
Featured Video
Asiamet Resources Ltd (LON:ARS) CEO Peter Bird caught up with Proactive's Andrew Scott while in London to meet with...
Group Eleven's (CVE:ZNG) Bart Jaworski explains Stone Park has 1.3bln pounds of zinc/lead, making it the second largest...
Softcat PLC's (LON:SCT) CFO Graham Charlton tells Proactive business is booming for the IT equipment supplier.
Unashamedly a middleman, Softcat supplies everything small and large organisations need IT-wise and posted sales growth in 22% in the year just ended.
Growth should continue says Charlton as...
Matthew Idiens, Chief executive of Rose Petroleum PLC (LON:ROSE), tells Proactive's Andrew Scott activity continues apace on the ground in Utah’s Paradox basin and they're expecting to drill the first well in the project later this year.
It comes after Rose increased its footprint in the Paradox basin, and as it...
Alastair Riddell, chairman of Feedback plc (LON:FDBK), tells Proactive's Andrew Scott they've merged two of their subsidiaries as part of plans to restructure and simplify the business.
Feedback snapped up Cambridge Computed Imaging and TexRAD back in 2014 and both have been operating as wholly-owned subsidiaries ever...
Andrew Newland, chief executive of ANGLE PLC (LON:AGL), tells Proactive's Andrew Scott that researchers using their Parsortix device for capturing circulating tumour cells may have found another “clear high value application” for the system.
Not only have they discovered a method of successfully culturing the cancer...
ImmuPharma PLC (LON:IMM) CEO Dimitri Dimitriou and chairman Tim McCarthy discuss with Proactive Investors the top-line results from their phase III trial of the drug Lupuzor.
The data revealed Lupuzor was more effective than the placebo (52.5% versus 44.6%) however because the response rate for those taking the...
David Price, chief executive of Papua Mining PLC (LON:PML), tells Proactive field mapping and rock sampling at the Marengo gold project in Queensland, Australia has defined two intrusions with multiple veins.
The veins host strongly-anomalous gold, copper and silver mineralisation up to 59 grams per tonne (g/t) gold,...
Artem Volynets, non-executive director at Chaarat Gold Holdings Ltd (LON:CGH), tells Proactive's Andrew Scott the consolidation play in central Asia and surrounding countries of the former Soviet Union is an interesting way to play the sector.
''It's long overdue'', Volynets says.
''There is plenty of scope to...
Greg Hahn, president and CEO of Arizona Silver Exploration Inc (CVE:AZS, OTCQB:AZASF), discusses with Proactive's Andrew Scott the first encouraging findings from initial geophysical surveying at their new Sycamore Canyon gold-silver property in Graham county.
As revealed last month, Arizona Silver's struck a lease...
Kerim Sener, managing director of Ariana Resources plc (LON:AAU), tells Proactive Investors they produced 4,866 ounces of gold from the Kiziltepe project in Turkey during the first quarter to March 31 - an 8% increase quarter on quarter.
Ariana's expecting to produce 20,000 ounces for the full year.
Sener also...
Tom Becker, chief executive of Iofina plc (LON:IOF) tells Proactive Investors they maintained iodine production in the latest quarter even with an exceptionally bad US winter and less plants in operation.
Two of the plants (IO#3 and IO#5) were offline at the start of the quarter, while parts of the US were hit by one...
Graham Lumsden, chief executive of Motif Bio Plc (LON:MTFB), caught up with Proactive's Andrew Scott as the drug developer gears up for the commercial launch of its next-generation antibiotic.
Motif has successfully concluded a second phase III clinical trial on its lead drug, iclaprim and is preparing for regulatory...
Cliff Holloway, chief executive at Scancell Holdings Plc (LONSCLP), tells Proactive Investors they're raising up to £8mln through a placing and open offer – cash that will be used develop their three main drug candidates.
A placing and subscription at 12 pence a share will account for £6mln of the total.
The...
Andrew Pearson, LightwaveRF's (LON:LWRF) chief executive, explains the strategic thinking behind the change in its sales and marketing arrangements, its relationship with Apple and the new demonstration facility at John Lewis in Westfield, White City.
The market for smart home appliances is huge, he adds, with 18...
ImmuPharma PLC (LON:IMM) drug Lupuzor needs further analysis and certainly isn’t a bust, according to Vadim Alexandre, analyst at Northland Capital.
With shares down sharply, the reaction to phase III trial results for the lupus drug has been “knee-jerk” and probably not fully reflective of the outlook for the...
Dusty Nicol, president and CEO of Azarga Metals Corp (CVE:AZR), discusses with Proactive's Andrew Scott the recent resource upgrade for the Unkur copper-silver project in Russia - which lifted the size of the inferred resource by 47%.
The latest report shows an inferred resource (lower confidence) of 62mln tonnes at...
Chaarat Gold Holdings Limited’s (LON:CGH) management is confident it can more than double the mine life at its project in the Kyrgyz Republic through intensive drilling over the next two years.
It’s one of the most exciting packages I've seen, Dusty Nicol told Proactive and potentially the basis of a whole new mining...
David Barron, Miton Group PLC's (LON:MGR) chief executive, explains that new money flowing into its funds reflects an active management style and broad range of investment strategies.
Shareholders, too, have seen big cash hand-outs as profits have soared.
Barron believes the group is...
